HKEX – Talk Bio

Actionable Insights Powered by AI

Insilico Medicine Caps 2025 with Record HKD 2.277 Billion Hong Kong IPO

3 weeks ago talkbio0Tagged AI biotech, Drug Discovery, HKEX, Hong Kong IPO, Insilico Medicine

Insilico Medicine; Hong Kong IPO; AI biotech; HKEX listing; drug discovery

Chinese Biotechs Flock to Hong Kong IPOs for Next Growth Phase

1 year ago talkbio0Tagged Bay Area, Biotechnology, Chinese biotechs, Greater, HKEX, IPOs, Kong, listing reforms, Listings

Chinese biotechs, Hong Kong IPOs, biotechnology, pharmaceuticals, listing reforms, HKEX, Chapter 18A, biotech listings, Greater Bay Area.